Price history
¥2,037Latest+27.3%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview
Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
News
Key numbersShowing 8 of 20
PER
112.94How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.PBR
1.3How many times the company's net assets? Around 1x is generally considered a benchmark.ROE
1.2%Earning power. A figure above 10% is generally considered good.Dividend yield
0.0%The annual dividend as a percentage of the share price.Market capitalization
¥18bnShare price × number of shares. The value of the entire company.Equity ratio
84.4%The proportion of assets funded by money that does not have to be repaid.Operating margin
10.7%The percentage of revenue remaining from the company’s core business.Revenue growth (3 years)
7.5%The average annual growth in sales over the past three years.What to watch next
Continued monitoring of installations and orders in Japan and overseas for blood collection tube preparation equipment and systems, particularly BC and ROBO-9000RFID/large-scale RFID systems
Next earnings announcement through the fiscal year ending March 2027Impact HighLikelihood Medium
Continued strength in sales of consumables and other products, and the effectiveness of coordination between price revisions and promotional activities in response to higher raw material costs, including the impact on margins
Next earnings announcement through the second half of fiscal 2026Impact HighLikelihood High
Accumulation of additional orders and continuing contracts for large overseas projects in Southeast Asia, China and other markets
Second half of fiscal 2026 through the fiscal year ending March 2027Impact MediumLikelihood Medium
Progress in self-monitoring-related products, including launch timing and whether sales are recognized
Timing unknown, subject to progress disclosuresImpact MediumLikelihood Low
Continued maintenance and operation of regulatory and QMS-related approvals, including whether any material corrective actions or renewal delays arise
As needed, in line with earnings briefings and renewal schedulesImpact HighLikelihood Low
What to watch next
Who owns itTop holders total 57.6%
Listed holders 57.6%Everyone else 42.4%
株式会社オートニクス14.50%
Saneichi Masatomo (実吉 政知)12.63%
The Master Trust Bank of Japan, Ltd. (Trust Account)6.63%
Nomura Trust and Banking Co., Ltd. (Investment Trust Account)5.69%
NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS (standing proxy: The Hongkong and Shanghai Banking Corporation Limited, Tokyo Branch)5.45%
平澤 修3.67%
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED-HONG KONG PRIVATE BANKING DIVISION CLIENT A/C 8028-394841(常任代理人 香港上海銀行東京支店)3.29%
テクノメディカ従業員持株会2.29%
2 other listed holders3.42%
| Holder | Ownership (%) |
|---|---|
| 株式会社オートニクス | 14.50 |
| Saneichi Masatomo (実吉 政知) | 12.63 |
| The Master Trust Bank of Japan, Ltd. (Trust Account) | 6.63 |
| Nomura Trust and Banking Co., Ltd. (Investment Trust Account) | 5.69 |
| NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS (standing proxy: The Hongkong and Shanghai Banking Corporation Limited, Tokyo Branch) | 5.45 |
| 平澤 修 | 3.67 |
| THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED-HONG KONG PRIVATE BANKING DIVISION CLIENT A/C 8028-394841(常任代理人 香港上海銀行東京支店) | 3.29 |
| テクノメディカ従業員持株会 | 2.29 |
| 2 other listed holders | 3.42 |
This company's documents
Filings
Timely disclosures
- 2026-10-07Notice Regarding the Disposal of Treasury Shares as Restricted Stock for Employees
- 2026-08-06Notice Regarding the Results of the Acquisition of Treasury Shares through an Off-Auction Purchase (ToSTNeT-3) and the Completion of the Acquisition
- 2026-08-06(Correction) Partial Correction to the “Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 2027 (Japanese GAAP) (Non-consolidated)”
- 2026-08-05Notice Concerning the Repurchase of Treasury Shares and the Purchase of Treasury Shares through an Off-Auction Own-Share Purchase Transaction (ToSTNeT-3)
- 2026-08-05Notice Regarding Revisions to Earnings Forecasts for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027
- 2026-08-05Q1 Financial Results for the Fiscal Year Ending March 2027 [Japanese GAAP] (Non-consolidated)
- 2026-07-24Notice Regarding Completion of Payment for the Disposal of Treasury Shares as Stock-Based Compensation
- 2026-07-01Notice Regarding the Disposal of Treasury Shares as Stock-Based Compensation
7 more
- 2026-06-04Notice of Convocation of the 2026 Annual General Meeting of Shareholders and General Meeting Materials
- 2026-06-02Notice Concerning a Change in Accounting Auditor
- 2026-06-02Notice Regarding the Discontinuation of the Shareholder Benefit Program
- 2026-05-26Financial Results Presentation Materials for the Fiscal Year Ending March 2026
- 2026-05-11Notice Regarding Changes to the Dividend Policy
- 2026-05-11Notice Regarding Dividend from Retained Earnings
- 2026-05-11Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP] (Non-consolidated)
Threads
- 2026-10-07Disposal of Treasury Shares as Restricted Stock Compensation
- 2026-08-06Review of Product Lineup Following the Discontinuation of Production of Certain Models of Blood Collection Tube Preparation Equipment
- 2026-08-05Achieving Stable Growth in Net Sales and a 20% Ordinary Profit Margin on Net Sales
- 2026-08-05Expanding Market Share of Blood Collection Tube Preparation Equipment
- 2026-08-05Reduced dependence on blood collection tube preparation equipment through the expansion of specimen testing equipment
- 2026-08-05Expansion of Recurring Sales through Related Consumables and Maintenance Services
- 2026-08-05Rolling Out a Global Business Strategy
- 2026-08-05Pricing and Order Risks from Competitors’ Aggressive Discounting and Restrained Investment by Medical Facilities
56 more
- 2026-08-05Flexible capital policy through share repurchases
- 2026-08-05Change in Independent Auditor
- 2026-08-05Supply and Earnings Risks from Surging Crude Oil and Raw Material Prices and Procurement Difficulties
- 2026-07-01Executive Compensation Scheme Focused on Enhancing Corporate Value and Sharing Value with Shareholders
- 2026-06-23Stable Dividends and Growth Investment of Retained Earnings
- 2026-06-23Strengthening the earnings base through the continuous launch of original new products
- 2026-06-23Downward Pressure on the Clinical Laboratory Testing Market from Healthcare Cost-Containment Policies and Medical Service Fee Revisions
- 2026-06-23Currency, Distributor, and Maintenance and Servicing Risks Associated with Overseas Exports
- 2026-06-23Initiatives for Value-Added Products Focused on Medical Safety and Quality of Life
- 2026-06-23Sound Financing Based on Operating Cash Flow
- 2026-06-23Uncertainty in the Global Economy Surrounding the Slowdown in Emerging-Market Economies and the UK's Withdrawal from the EU
- 2026-06-23Enhancing Management Transparency and Efficiency and Establishing a Body for Prompt Decision-Making
- 2026-06-23Developing New Demand Through Compact Equipment Development and Direct Sales to Testing Laboratories
- 2026-06-23Transformation of healthcare delivery driven by the expanding role of community and home-based care
- 2026-06-23Addressing Social Issues through SDGs and ESG under the 2030 Long-Term Vision
- 2026-06-23Sustainable Growth Through Strategic Investment, Including M&A and Business Alliances
- 2026-06-04Expansion of a subscription business for systems, software and cloud-related products
- 2026-05-26Rationalizing the R&D Structure and Building a Lean Management Foundation
- 2026-05-26Revision of Consumables Prices in Response to Soaring Raw Material and Component Prices
- 2026-05-26Achieving Management Conscious of Cost of Capital and Share Price
- 2026-05-11Developing Point-of-Care Testing (POCT) and Health-Monitoring Products into New Revenue Pillars
- 2026-05-11Equipment sales weighted toward the second half and fourth quarter
- 2025-11-12Joint sales of electronic medical record and laboratory information systems and blood collection tube preparation equipment
- 2025-11-12Single-segment business focused on medical devices and consumables
- 2025-11-12Preparation for Applying the New Accounting Standard on Revenue Recognition
- 2025-11-12Preventing the Spread of COVID-19 and Maintaining Production and Product Supply
- 2025-06-24Sluggish growth in new demand due to high penetration of the installed base
- 2025-06-24Uncertainty Regarding R&D Timelines and Commercialization
- 2025-06-24Operation of the Risk Management Regulations and Emergency Reporting System for Top Management
- 2025-06-24Business Impacts of Climate Change, Extreme Weather and Calls for Action
- 2025-06-24Preparation for Applying the Lease Accounting Standard in 2028
- 2024-06-26Concentrating Management Resources on R&D and Sales through Outsourced Manufacturing
- 2024-06-26Compliance Awareness and Remediation of Internal Controls over Financial Reporting
- 2024-06-26Strengthening governance through the appointment of external personnel and an external whistleblowing hotline
- 2024-06-26Concentration of sales in the blood collection tube preparation equipment business and reliance on market share
- 2024-06-26Long sales cycles and delayed decision-making for blood collection tube preparation equipment
- 2024-06-26Risk of supply suspension due to problems at contract manufacturers
- 2024-06-26Regulatory Compliance under the Pharmaceutical Affairs Law, QMS Ministerial Ordinance, and Other Regulations
- 2024-06-26Transition to a Company with an Audit and Supervisory Committee
- 2024-06-26Risk of Patent Infringement and Intellectual Property Rights Protection
- 2024-06-26Severance of Relationships with Antisocial Forces and Exclusion Framework
- 2024-06-26Timely and Appropriate Disclosure of Material Management-Related Information
- 2024-06-26Impact of the Spread of COVID-19 on the Economy, Medical Facilities and Overseas Projects
- 2024-06-26Business impact from concentration in sales channels and end customers
- 2024-06-26Addressing Director Liability Risks Through Directors and Officers Liability Insurance
- 2024-06-26Two-Stage Quality Inspections for Consumables and Lot Recalls in the Event of Defects
- 2024-06-26Change in Tokyo Stock Exchange Listing Segment
- 2023-06-28Risk of Delays in Product Supply Due to Semiconductor Shortages
- 2023-06-28Decline in sales due to unstable procurement of electrolyte analyzers
- 2022-06-28Risk of Loss of Trust Due to Defects in Medical-Related Equipment
- 2022-06-28Application of New Accounting Standards on Fair Value Measurement
- 2021-06-25Occurrence of Improper Accounting Treatment in Sales Transactions
- 2020-06-25Construction of new manufacturing facilities for logistics centers and analytical equipment consumables
- 2019-06-26Improving the Earnings Structure by Expanding Service Capabilities and Offering Value-Added Proposals
- 2016-08-19Maintaining Supporting Documentation for Revenue Recognition
- 2016-08-19Remediation of the inventory and stock management system, including external warehouses